We showed CCND1 amplification in a SyS cell line and CCND1 rearrangement in a small percentage of cells in a subset of patient samples, although possible fusion partners and the significance of these rearrangements in a small subset of tumor cells remain elusive. The gene discussed is CCND1; the disease is neoplasm.